PL2306995T3 - Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO - Google Patents

Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO

Info

Publication number
PL2306995T3
PL2306995T3 PL09777548T PL09777548T PL2306995T3 PL 2306995 T3 PL2306995 T3 PL 2306995T3 PL 09777548 T PL09777548 T PL 09777548T PL 09777548 T PL09777548 T PL 09777548T PL 2306995 T3 PL2306995 T3 PL 2306995T3
Authority
PL
Poland
Prior art keywords
protease inhibitors
modified protease
antitumor properties
antitumor
properties
Prior art date
Application number
PL09777548T
Other languages
English (en)
Inventor
Ferdinando Nicoletti
Yousef Al-Abed
Gianni Garotta
Original Assignee
Onconox Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onconox Aps filed Critical Onconox Aps
Publication of PL2306995T3 publication Critical patent/PL2306995T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL09777548T 2008-08-01 2009-07-30 Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO PL2306995T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8555508P 2008-08-01 2008-08-01
PCT/EP2009/005526 WO2010012466A1 (en) 2008-08-01 2009-07-30 Antitumor properties of no modified protease inhibitors
EP09777548.0A EP2306995B1 (en) 2008-08-01 2009-07-30 Antitumor properties of no modified protease inhibitors

Publications (1)

Publication Number Publication Date
PL2306995T3 true PL2306995T3 (pl) 2014-12-31

Family

ID=41139301

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09777548T PL2306995T3 (pl) 2008-08-01 2009-07-30 Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO

Country Status (10)

Country Link
US (1) US8563578B2 (pl)
EP (1) EP2306995B1 (pl)
JP (1) JP2011529864A (pl)
CN (1) CN102131501A (pl)
DK (1) DK2306995T3 (pl)
ES (1) ES2509493T3 (pl)
HR (1) HRP20140929T1 (pl)
PL (1) PL2306995T3 (pl)
PT (1) PT2306995E (pl)
WO (1) WO2010012466A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102260243B (zh) * 2011-06-09 2013-08-14 沈阳亿灵医药科技有限公司 沙奎那韦琥珀酸半酯盐及其制剂
US20150283127A1 (en) * 2012-11-20 2015-10-08 Onconox Aps Saquinavir-no for immunomodulation
CN107281462A (zh) * 2017-08-21 2017-10-24 滨州医学院 沙奎拉韦减轻伊立替康毒性的医药新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
US20090131342A1 (en) * 2004-01-22 2009-05-21 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
JP5198063B2 (ja) * 2004-08-26 2013-05-15 アッパラオ・サティアム 新規バイオ開裂性リンカー

Also Published As

Publication number Publication date
EP2306995A1 (en) 2011-04-13
US20110195939A1 (en) 2011-08-11
CN102131501A (zh) 2011-07-20
ES2509493T3 (es) 2014-10-17
WO2010012466A8 (en) 2010-04-22
HRP20140929T1 (hr) 2014-12-05
PT2306995E (pt) 2014-10-06
DK2306995T3 (da) 2014-10-20
EP2306995B1 (en) 2014-07-30
WO2010012466A1 (en) 2010-02-04
JP2011529864A (ja) 2011-12-15
US8563578B2 (en) 2013-10-22

Similar Documents

Publication Publication Date Title
ZA200906946B (en) Inhibitors of iap
EP2440054A4 (en) PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING
ZA201006719B (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
IL218018A0 (en) Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
ZA201100898B (en) Novel inhibitors
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
IL215506A0 (en) Protease inhibitors
GB0820856D0 (en) Novel inhibitors of flavivirus replication
IL215645A0 (en) Inhibitors of cognitive decline
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
IL217833A0 (en) Inhibitors of cognitive decline
PL2506840T3 (pl) Zastosowania inhibitorów czynnika indukowalnego niedotlenieniem
ZA201004765B (en) Inhibitors of iap
GB0817926D0 (en) Articles of clothiing
EP2313426A4 (en) NEW PROTEASE INHIBITORS
ZA201102179B (en) Protease inhibitors
PT2306995E (pt) Propriedades antitumorais de inibidores de protease não modidficados
SI2411376T1 (sl) INHIBITORJI NF-kB
GB0817425D0 (en) Protease inhibitors
GB0915927D0 (en) Novel inhibitors
AU2009902917A0 (en) Peptidase inhibitors
IL214333A0 (en) Carbamoylphosphonates as inhibitors and uses thereof
GB0816125D0 (en) Novel inhibitors
GB0903650D0 (en) Glyoalase inhibitors
GB0902661D0 (en) Inhibitors